Stoyanova Lab News
Identification of a new serum biomarker for clinically significant prostate cancer
Exciting new results from our lab collaborative work reveal PTN as a new serum biomarker of pro-metastatic prostate cancer. Congratulations Shiqin and all collaborators!
Identification of a new important regulator of prostate cancer growth and metastasis
New study from our lab demonstrates plectin is an important regulator of prostate cancer growth and metastatic colonization. Congratulations Mark, Meghan and team.
Tanya Stoyanova receives 2020 Society of Basic Urologic Research Young Investigator Award from the Society of Basic Urologic Research
Congratulations Tanya!
En-chi Hsu receives Travel Award from the Society of Basic Urologic Research
Congratulations En-chi!
Merve Aslan receives Travel Award from the Society of Basic Urologic Research
Congratulations Merve!
Exciting news: Dr. Manoj Kumar joins Stoyanova lab!
Welcome to the team Manoj!
New review article on prostate cancer therapies published
Stoyanova Lab publishes a review article discussing second-generation anti-androgen therapies for prostate cancer. Congratulations Meghan!
Stoyanova Lab Receives NCI R01 Grant
Stoyanova lab is awarded NIH/NCI R01 funding for the proposal entitled:
“Elucidating the Role of UCHL1 in Aggressive Prostate Cancer”
The goal of the project is to identify new molecular mechanisms underlying the development of highly aggressive neuroendocrine prostate cancer and develop new therapies for the matasatic disease.
Congratulations!
Dr. Tanya Stoyanova Receives NCI R01/R37 MERIT Award
Dr. Stoyanova is awarded the NIH/NCI R01/R37 MERIT Award for her proposal entitled:
“Elucidating the Role of Trop2 in Prostate Cancer”
The goal of the project is to test the role of a cell surface receptor activation in aggressive prostate cancer. The study will define novel mechanisms that contribute to the development of advanced prostate cancer and test new therapies for the advanced disease.
Congratulations Dr. Stoyanova!
